Oral News and Research

RSS

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP.

15 Sep 2012

Severe egg allergy treatment shows promise

Specific oral tolerance induction with raw hen’s egg can reduce the severity of egg allergy in affected children, show study findings.

14 Sep 2012

Objective response rate promising after crizotinib for NSCLC

More than half of the latest evaluated participants from the ongoing phase II PROFILE 1005 trial of crizotinib against ALK-positive advanced non-small-cell lung cancer, achieved an objective tumor response, report researchers.

14 Sep 2012

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.

14 Sep 2012

Insufficient evidence to support effectiveness of black cohosh for menopausal symptoms

Although many women coping with hot flashes and other distressing symptoms of menopause have turned to black cohosh supplements as a treatment alternative, a new review by The Cochrane Library finds no evidence that the herb is effective.

14 Sep 2012

Low income and minority households more likely to have child with undiagnosed food allergy

More can be done to properly manage the care of American children with food allergies, especially when it comes to diagnostic testing and recognizing non-visual symptoms of severe allergic reactions, according to a new Northwestern Medicine study.

14 Sep 2012

Montelukast possible surgery alternative for obstructive sleep apnea

Leukotriene modifiers may provide a noninvasive treatment option for children with nonsevere obstructive sleep apnea, say researchers.

13 Sep 2012

Crizotinib may be effective treatment option for NSCLC subtype

Phase I trial results show that the chemotherapy drug crizotinib may be fast-acting and produce long-lasting treatment responses in patients with anaplastic lymphoma receptor tyrosine kinase-positive non-small-cell lung cancer.

13 Sep 2012

Addition of sorafenib to chemotherapy does not prolong survival

The addition of sorafenib to gemcitabine/cisplatin fails to provide any additional benefit in chemotherapy-naïve patients with nonsquamous non-small-cell lung cancer, research shows.

13 Sep 2012

Dabigatran increasingly being used off-label

Dabigatran has increasingly been used for off-label indications, including venous thromboembolism, in the USA between 2007 and 2011, a study suggests.

13 Sep 2012

Infants’ oral microbiota differs according to feeding method

The oral microbiota of 3-month old infants is distinguishable by whether they are breast- or formula-fed, show study findings.

13 Sep 2012

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing novel antibiotics effective against antibiotic-resistant bacteria, presented new, positive Phase 2 clinical data on its lead drug candidate, eravacycline (TP-434), on September 11, 2012, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

13 Sep 2012

Angiopoietin-like protein 2 level linked to incident diabetes

Elevated angiopoietin-like protein 2 levels are associated with the development of Type 2 diabetes, show findings from a Japanese study.

12 Sep 2012

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years.

12 Sep 2012

Latinos more likely to store fat in the pancreas and develop type 2 diabetes

Latinos are more likely to store fat in the pancreas and are less able to compensate by excreting additional insulin, a Cedars-Sinai study shows.

12 Sep 2012

Progestogens may avoid early child birth in women with prior preterm births

Pregnant women who have had prior preterm births may avoid a subsequent early birth if given progestogens, which are natural or synthetic forms of progesterone, a female hormone that naturally increases during pregnancy, a Vanderbilt analysis shows.

11 Sep 2012

Jazz Pharmaceuticals receives new U.S. patent for Xyrem oral solution

Jazz Pharmaceuticals plc. today announced that a new patent related to Xyrem (sodium oxybate) oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy" will issue today.

11 Sep 2012

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

11 Sep 2012

Antioxidants improve sperm quality in infertile men

Infertile men may benefit from taking antioxidant supplements to improve sperm quality, study findings suggest.

10 Sep 2012

Oral News and Research

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Severe egg allergy treatment shows promise

Objective response rate promising after crizotinib for NSCLC

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

Insufficient evidence to support effectiveness of black cohosh for menopausal symptoms

Low income and minority households more likely to have child with undiagnosed food allergy

Montelukast possible surgery alternative for obstructive sleep apnea

Crizotinib may be effective treatment option for NSCLC subtype

Addition of sorafenib to chemotherapy does not prolong survival

Dabigatran increasingly being used off-label

Infants’ oral microbiota differs according to feeding method

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Angiopoietin-like protein 2 level linked to incident diabetes

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

Latinos more likely to store fat in the pancreas and develop type 2 diabetes

Progestogens may avoid early child birth in women with prior preterm births

Jazz Pharmaceuticals receives new U.S. patent for Xyrem oral solution

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Antioxidants improve sperm quality in infertile men

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News